Did intense adverse media publicity impact on prescribing of paroxetine and the notification of suspected adverse drug reactions? Analysis of routine databases, 2001-2004.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British Journal of Clinical Pharmacology

• Publication date

  2006-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1365-2125.2005.02527.XPMID 16433877PMCID PMC1884992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants

  2005cited by this paper
• Antidepressants and suicide: what is the balance of benefit and harm

  2004cited by this paper
• A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.

  2003cited by this paper
• A model for the future conduct of pharmacovigilance

  2003cited by this paper
• Withdrawal from paroxetine can be severe, warns FDA

  2002cited by this paper
• Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351

  2001cited by this paper
• Withdrawal symptoms associated with paroxetine discontinuation in a nine-year-old boy.

  2000cited by this paper
• Permutation tests for joinpoint regression with applications to cancer rates.

  2000cited by this paper
• Selective serotonin reuptake inhibitors.

  1998cited by this paper
• Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system

  1997cited by this paper
• More cases of paroxetine withdrawal syndrome

  1996cited by this paper
• Fitting Segmented Regression Models by Grid Search

  1980cited by this paper

• The Persistent Ambiguity of Adverse Drug Reactions

  2025cites this paper
• Tyrosine Kinase Inhibitors and Interstitial Lung Disease: A Disproportionality Analysis Using the European Post-marketing EudraVigilance Database

  2025cites this paper
• Analysis of spontaneous reports of suspected adverse reactions after vaccination against COVID-19 in Slovakia

  2023cites this paper
• Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases

  2023cites this paper
• Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of Publicity

  2022cites this paper
• Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta‐analysis

  2020cites this paper
• Statins in a Distorted Mirror of Media

  2020cites this paper
• Guidance impact on primary care prescribing rates of simple analgesia: an interrupted time series analysis in England

  2020cites this paper
• The cooccurrence of heightened media attention and adverse drug reaction reports for hormonal contraception in the United Kingdom between 2014 and 2017

  2020influential citation
• Antidepressants, withdrawal, and addiction; where are we now?

  2019cites this paper
• Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG‐CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan

  2018cites this paper
• How do smoking cessation medicines compare with respect to their neuropsychiatric safety? A protocol for a systematic review, network meta-analysis and cost-effectiveness analysis

  2017cites this paper
• Measuring the impact of medicines regulatory interventions – Systematic review and methodological considerations

  2017cites this paper
• Pattern of statin use changes following media coverage of its side effects

  2017cites this paper
• Media attention regarding sudden cardiac death associated with domperidone use does not affect in hospital ECG recording

  2017cites this paper
• Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides

  2016cites this paper
• Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study

  2016cites this paper
• Assessment of the impact of the Scottish public health campaign on patient reporting of adverse drug reactions

  2016cites this paper
• Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study

  2016cites this paper
• The Pharmacovigilance Syndrome.

  2015cites this paper
• Reporting of drug induced depression and fatal and non-fatal suicidal behaviour in the UK from 1998 to 2011

  2014cites this paper
• Health provider factors associated with reporting of adverse drug reactions in Kenyatta national hospital

  2014cites this paper
• Side effects of drugs essay: Observational studies in assessing benefits and harms: double standards?

  2014cites this paper
• Smoking cessation treatment and risk of depression, suicide, and self harm in the Clinical Practice Research Datalink: prospective cohort study

  2013cites this paper
• Communicating risk effectively

  2013cites this paper
• Physicians' prescribing preferences were a potential instrument for patients' actual prescriptions of antidepressants☆

  2013cites this paper
• Physicians' preferences were a potential instrument for patients' actual prescriptions antidepressants.

  2013cites this paper
• When Direct Health‐Care Professional Communications Have an Impact on Inappropriate and Unsafe Use of Medicines

  2013cites this paper
• Studies on pharmaceutical markets

  2013cites this paper
• A 10-Year Analysis of the Effects of Media Coverage of Regulatory Warnings on Antidepressant Use in The Netherlands and UK

  2012cites this paper
• Adverse Events Following a Medication Change: Psychological Contributors to a Health Scare

  2012cites this paper
• Impact of television coverage on the number and type of symptoms reported during a health scare: a retrospective pre–post observational study

  2012cites this paper
• Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability

  2012cites this paper
• Publication trends in newspapers and scientific journals for SSRIs and suicidality: a systematic longitudinal study

  2011cites this paper
• Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network.

  2011cites this paper
• Use of attention deficit/hyperactivity disorder pharmacological treatment following the public discussion on cardiovascular safety and the introduction of medication guides for central nervous system stimulants and atomoxetine

  2010cites this paper
• Media attention and the influence on the reporting odds ratio in disproportionality analysis: an example of patient reporting of statins

  2010cites this paper
• Patterns of antidepressant use in Quebec children and adolescents: trends and predictors.

  2010cites this paper
• Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.

  2009cites this paper
• Health Advisories and Patterns of Patient Monitoring Among New Users of Antidepressant Medications

  2009cites this paper
• The population impact on incidence of suicide and non-fatal self harm of regulatory action against the use of selective serotonin reuptake inhibitors in under 18s in the United Kingdom: ecological study

  2008cites this paper
• Chapter 3 – Adverse drug reactions

  2008cites this paper
• Selective serotonin re-uptake inhibitor warnings and trends in exposures reported to poison control centres in Texas.

  2008cites this paper
• Suicide rates in young men in England and Wales in the 21st century: time trend study

  2008cites this paper
• Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

  2007cites this paper
• Medicines and the media

  2006cites this paper
• Systematic review of resource utilization in the hospital management of deliberate self-harm

  2006cites this paper
• Closing the antidepressant efficacy gap between clinical trials and real patient populations

  2006cites this paper